MELBOURNE & ONLINE: ‘The Dynamic Board’ Series – Making the Most of your AGM and Annual Report

Rebecca has spent the last 25 years working with fast growth, innovative based ASX companies in the technology industry working within the Health, Telecommunications, Energy, and Financial sectors providing advice on stakeholder communications, issues management, investor and corporate relations, and business strategy to private and public companies, research institutes, governments, and asset managers. She is currently a NED of four technology-based ASX businesses including Chair of Alcidion Ltd (ASX: ALC), providing enterprise technology software in hospitals and NED at Hansen (ASX: HSN) which provides enterprise technology solutions in the telecommunications and energy sectors.

Cameron is the Managing Director of Bio101, a financial services firm providing accounting, transaction advisory, company secretarial and tax services specialising in the healthcare and life science sectors. A qualified Chartered Accountant and registered tax agent, Cameron acts as CFO and Company Secretary for a number of ASX listed and Venture Capital investee companies. Cameron has assisted a number of companies through the Initial Public Offering (IPO) process, capital raisings and M&A transactions.

Alastair is an experienced Corporate and Commercial lawyer specialising in corporate governance and commercial contracting.  He has a broad-based corporate and commercial practice that extends across several sectors, including health and financial services.  Alastair has advised private, government, not-for-profit and mutual entities on a wide range of corporate and commercial matters, including governance and structuring issues, directors’ and officers’ duties, ESG, general Corporations Act 2001 (Cth) advice and commercial contracting, including joint ventures and collaborations, private health insurer contracting with hospitals and other service providers, public funding and commissioning/sub-funding arrangements and not-for-profit mergers and transitioning.

Alastair has specialist knowledge of corporate governance issues and has extensive experience in drafting, amending and replacing constituent documents, including constitutions, shareholders’ agreements and members’ agreements.  He regularly provides governance training to private, public and not-for-profit sector entities and advises on officer protection and board representation arrangements.

Alastair has assisted numerous companies limited by guarantee with start-up, governance, structuring, funding, commissioning/contracting and winding up issues, both in the not-for-profit context and where the entity is owned or controlled by government.  This includes advising on not-for-profit mergers and similar transitioning or exit arrangements.  He also assists in designing and implementing ‘back-to-back’ contracting arrangements for government-funded entities.

Since 2010, Alastair has assisted various participants in the Australian primary health care sector (including Primary Health Networks, and the predecessor Medicare Locals and Divisions of General Practice) in connection with commissioning and other commercial arrangements, governance and structuring and various federal and state reforms.

Alastair is a regular presenter of seminars and workshops on directors’ and officers’ duties, governance and structuring issues and ESG.

Alastair has a Bachelor of Laws (Honours) and Bachelor of Arts (Honours) from the University of Melbourne, and is a Graduate of the Australian Institute of Company Directors (Order of Merit).

An experienced corporate lawyer, Lis advises listed and private companies, multinationals, and not-for-profit organisations on their structure, governance, operations and strategy.  Her clients appreciate her commitment to building long term relationships and understanding their culture and strategy so as to deliver timely, thoughtful and practical advice.

At a strategic level, Lis collaborates with boards and senior executives on significant transactions — such as capital raisings, restructuring, strategic collaborations and mergers and acquisitions (public and private).  Lis’s deep experience and practical insights are particularly appreciated by growing clients who seek her guidance on how to plan and execute these important projects.

Lis also helps organisations review their governance framework so that it is “fit for purpose”, and provides emotionally intelligent advice on engaging with key stakeholders around complex member approvals, or dealing with conflicts of interest.  In this, Lis brings additional perspectives as a graduate of the Australian Institute of Company Directors.  For listed companies, Lis gives practical direction on meeting continuous disclosure obligations.

At an operational level, Lis guides clients in how to integrate business ethics and legal compliance into “business as usual”, training boards and managers on fulfilling their key legal obligations, such as privacy and directors’ & officers’ duties.  Lis also designs contract review frameworks in line with the organisation’s risk appetite as well as drafting and negotiating complex contracts.

Lis’s strong focus on Life Sciences and Healthcare is reflected in her appointment as deputy chair of AusBiotech’s AusMedtech Advisory Group, and as a member of AusBiotech’s State Committee for NSW.   Lis has also actively participated in AusBiotech industry projects including AusBiotech’s Guide for Directors of Life Sciences Companies, AusBiotech’s Guide for Investors in Life Sciences Companies and pitching workshops for Life Sciences CEOs.  She enjoys being a “connector” between people in her network, to strengthen the Australian life sciences ecosystem.